AstraZeneca ups annual outlook on strong cancer drugs demand

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo Acquire Licensing Rights Nov 9 (Reuters) - Drugmaker AstraZeneca (AZN.L) raised its annual core profit outlook on Thursday, helped by strong demand for its oncology and rare blood…#astrazeneca #macclesfield
Source: Reuters: Health - Category: Consumer Health News Source Type: news